AI has enormous potential to improve the quality of health care, enable early diagnosis of diseases, and reduce costs. But if implemented incautiously, AI can exacerbate health disparities, endanger privacy rights, and perpetuate bias. STAT is exploring these possibilities and pitfalls, illuminating best practices while identifying regulatory gaps.
Coverage supported by:
STAT spoke to dozens of experts, company executives, and officials to glean insight into the FDA breakthrough designation program.
Read The Story
advertisement
